EDGAR Filing Documents for 0001213900-21-005456

Form 8-K - Current report:

SEC Accession No. 0001213900-21-005456

Filing Date

2021-01-29

Accepted

2021-01-29 17:27:39

Documents

Period of Report

2021-01-28

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	ea134164-8k_biotechacq.htm	8-K	39712
2	UNDERWRITING AGREEMENT, DATED JANUARY 25, 2021 BY AND BETWEEN THE COMPANY AND CA	ea134164ex1-1_biotechacq.htm	EX-1.1	293776
3	AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION	ea134164ex3-1_biotechacq.htm	EX-3.1	475869
4	WARRANT AGREEMENT, DATED JANUARY 25, 2021, BY AND BETWEEN THE COMPANY AND CONTIN	ea134164ex4-1_biotechacq.htm	EX-4.1	185652
5	LETTER AGREEMENT, DATED JANUARY 25, 2021, BY AND AMONG THE COMPANY, ITS OFFICERS	ea134164ex10-1_biotechacq.htm	EX-10.1	46496
6	INVESTMENT MANAGEMENT TRUST AGREEMENT, DATED JANUARY 25, 2021, BY AND BETWEEN TH	ea134164ex10-2_biotechacq.htm	EX-10.2	83939
7	REGISTRATION RIGHTS AGREEMENT, DATED JANUARY 25, 2021, BY AND BETWEEN THE COMPAN	ea134164ex10-3_biotechacq.htm	EX-10.3	101767
8	ADMINISTRATIVE SUPPORT AGREEMENT, DATED JANUARY 25, 2021, BY AND BETWEEN THE COM	ea134164ex10-4_biotechacq.htm	EX-10.4	13386
9	SPONSOR WARRANTS PURCHASE AGREEMENT, DATED JANUARY 25, 2021 BY AND BETWEEN THE C	ea134164ex10-5_biotechacq.htm	EX-10.5	49425
10	PRESS RELEASE, DATED JANUARY 25, 2021	ea134164ex99-1_biotechacq.htm	EX-99.1	7574
11	PRESS RELEASE, DATED JANUARY 28, 2021	ea134164ex99-2_biotechacq.htm	EX-99.2	7455
	Complete submission text file	0001213900-21-005456.txt		1306352

Mailing Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001

Business Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001 8586920539

Biotech Acquisition Co (Filer) CIK: 0001825413 (see all company filings)